Allied Healthcare Products (AHPI) 1.56 $AHPI
How it All Plays Out: Research Reports on Align Technology, Alimera, Alkermes, Alliance HealthCare Services, and Allied Healthcare Products
PR Newswire - Tue Feb 03, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Align Technology (NASDAQ: ALGN), Alimera (NASDAQ: ALIM), Alkermes (NASDAQ: ALKS), Alliance HealthCare Services, (NASDAQ: AIQ), and Allied Healthcare Products (NASDAQ: AHPI). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ALGN: 56.90 (-0.34), ALIM: 5.16 (unch), AHPI: 1.56 (unch), ALKS: 71.40 (-1.89), AIQ: 24.99 (+0.27)
Global COPD and Asthma Devices Market (Product Types and Geography) 2013 - 2020
M2 - Wed Dec 03, 8:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/8nv92w/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020" report to their offering. The global COPD and asthma devices market would reach $34.3 billionby 2020, registering a CAGR of 4.5% during 2014 - 2020. Considering the growth and market size, Dry Powder Inhalers (DPIs) will be the most lucrative market segment of the COPD and Asthma devices (inhalers) market by 2020. Metered Dose Inhalers (MDIs) are the largest revenue generating segment currently and would maintain the stand till 2020. The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices. Despite notable advantages of the COPD and Asthma devices, some factors such as environmental concerns are likely to impede the growth of COPD and Asthma devices market. It is observed that the inhalers, particularly the MDIs, release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is negatively impacting growth of the MDIs segment. Consumption pattern will shift to better alternatives, namely the DPIs. The Soft Mist Inhalers (SMIs), which are another type of inhalers, deliver metered dosage of medication as a soft mist. Such form of drug delivery is -65% to 80% more efficacious than its peers and will eventually display higher growth as compared to its peers. Nebulizers, electric or battery powered machines that dispense medication as a fine mist, are ideal for home healthcare set-up for debilitated patients, geriatrics and children. Nebulizers segment thus holds about 13% of the global COPD and Asthma devices market; however, the nebulizers market is forecast to have diminishing growth through 2020 as nebulizers are rendered ineffectual, as POC or portable COPD and Asthma devices due to its larger set up. Key findings of the study: - Drug powder inhalers (DPIs) segment will grow at a CAGR of 5.3% during the forecast period, fastest among all - North American market would be one of the most lucrative markets, in terms of growth - European market for COPD and asthma devices would reach $10 billion by 2020, with the CAGR of 4.8% - Within the nebulizers segment markets, compressor nebulizers would be most lucrative, growing at 7% CAGR during the forecast period and compressor nebulizers would garner 81.5% market share by 2020 Specific focus to achieve product differentiation and thus gain competitive advantage drives the development of new product variants of COPD and Asthma devices. In accordance to the afore-mentioned trend, the market has witnessed steady stream of product launch. Key product manufacturing companies profiled in the report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc. and Baxter International. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL COPD AND ASTHMA DEVICES MARKET BY PRODUCT TYPE, 2013-2020, $MILLION CHAPTER 5 GLOBAL COPD AND ASTHMA DEVICES MARKET BY GEOGRAPHY, 2013-2020, $MILLION CHAPTER 6 COMPANY PROFILES - 3M Health Care - Allied Healthcare Products Inc. - AstraZeneca Plc - Baxter International - GF Healthcare Products - GlaxoSmithKline Plc - Lincare Holdings Inc. - Merck & Co. - Novartis AG - Philips Healthcare - Smith Medicals - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/8n...l_copd_and
BAX: 70.39 (+0.31), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), AHPI: 1.56 (unch), GSK: 47.94 (+1.99), NVS: 102.20 (-0.17)
OTC Daily Alert Stock Watch - Allied Healthcare Products, Inc (NASDAQ: AHPI)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
AHPI: 1.56 (unch)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 17.13 (+0.15), COV: 106.71 (-1.36), AHPI: 1.56 (unch)
Nasdaq stocks posting largest volume increases
AP - Fri Oct 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
URBN: 38.47 (+0.27), DLHC: 2.21 (-0.06), LMOS: 17.98 (-0.14), RDI: 12.03 (unch), AHPI: 1.56 (unch), COCO: 0.02 (-0.01), AGYS: 10.06 (-0.16), HCCI: 12.05 (-0.14), NAUH: 3.17 (-0.02), KTEC: 12.53 (-0.02), MBTF: 5.37 (-0.01), CZFC: 12.30 (-0.03), RDIB: 12.31 (-0.07)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 11:52AM CDT
TTPH: 35.18 (-0.73), MNOV: 3.62 (-0.56), DLHC: 2.21 (-0.06), RADA: 2.46 (+0.01), ESI: 7.58 (-0.29), RPRX: 8.76 (+0.09), VSR: 3.42 (-0.02), HCCI: 12.05 (-0.14), ANR: 1.27 (+0.03), BIOF: 7.28 (+0.01), URBN: 38.47 (+0.27), GBIM: 7.85 (+0.25), APT: 2.88 (+0.17), NLNK: 38.84 (+1.51), AHPI: 1.56 (unch), LIME: 2.69 (+0.14), QLGC: 14.48 (+0.48), WLB: 28.91 (+0.29), IBIO: 0.90 (+0.36), VPCO: 1.02 (+0.01)
Second healthcare worker contracts Ebola in U.S.
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 4:25AM CDT
BCRX: 10.06 (-0.09), DAL: 44.50 (-0.31), SHO: 17.49 (-0.14), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), H: 59.51 (-0.14), HOT: 78.55 (+0.67), STAY: 20.74 (+0.21), LUV: 43.30 (-0.20), INO: 6.80 (-0.15), INN: 13.05 (+0.08), HLT: 28.57 (+0.13), CHH: 61.75 (+1.14), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), SRPT: 12.76 (+0.11), NLNK: 38.84 (+1.51), AHPI: 1.56 (unch), IBIO: 0.90 (+0.36), LAKE: 10.18 (+0.89), AAL: 48.39 (+0.51), IHG: 40.34 (-1.03), NSPH: 0.25 (unch), HA: 18.72 (-0.31), AHT: 10.63 (-0.04), LHO: 41.14 (-0.08), VSR: 3.42 (-0.02), GSK: 47.94 (+1.99), MAR: 79.39 (+0.37), ALGT: 178.42 (-4.07), UAL: 66.23 (-1.11), SKYW: 13.84 (+1.88), HEB: 0.25 (+0.01), PLX: 1.84 (-0.04), SMED: 4.75 (-0.04)
Market Maker Surveillance Report. AHPI, APT, LAKE, IBIO, CDXS, MPO, Losing Stocks With Lowest Price Friction For Tuesday, October 14th 2014
M2 - Wed Oct 15, 3:11AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4904 companies with "abnormal" market making, 2632 companies with positive Friction Factors and 2319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Allied Healthcare Products Inc (NASDAQ:AHPI), Alpha Pro Tech Ltd (NYSE:APT), Lakeland Industries Inc (NASDAQ:LAKE), Ibio Inc (NYSE:IBIO), Codexis Inc (NASDAQ:CDXS), Midstates Petroleum Company Inc (NYSE:MPO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
APT: 2.88 (+0.17), AHPI: 1.56 (unch), MPO: 1.00 (-0.02), CDXS: 3.42 (+0.07), IBIO: 0.90 (+0.36), LAKE: 10.18 (+0.89)
Global Nebulizers Market Industry Analysis 2014-2019 - Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers
M2 - Mon Sep 01, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l9s298/nebulizers_market) has announced the addition of the "Nebulizers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global nebulizers market was valued at USD 610.0 million in 2012 and is expected to grow at a CAGR of 6.5% from 2013 to 2019, to reach an estimated value of USD 937.7 million by 2019. The global nebulizers market is segmented based on product types into pneumatic nebulizer, ultrasonic nebulizer and mesh nebulizer. In 2012, pneumatic nebulizer accounted for the largest market share of the global nebulizers market owing to its cost effective nature and easy to handle. Pneumatic nebulizers are further classified as vented and breath-actuated pneumatic nebulizers. In 2012, breath actuated pneumatic nebulizers segment accounted for the largest share of the global pneumatic nebulizers market due to factors such as cost effectiveness and efficient drug delivery. Moreover, the breath-actuated pneumatic nebulizers segment is expected to grow at the highest CAGR from 2013 to 2019 in the global pneumatic nebulizers market. Ultrasonic nebulizers are further segmented into standalone and portable ultrasonic nebulizers. Portable ultrasonic nebulizers accounted for the largest share as they are easy to handle and operate. North America accounted for the largest share in the global nebulizers market in 2012 owing to rising prevalence of respiratory diseases such as asthma, COPD and cystic fibrosis. In addition, increasing government initiatives in this region also supported the growth of nebulizers market in the North American region. Asia-Pacific was observed to be an emerging market for nebulizers and is expected to grow at the highest CAGR from 2013 to 2019. This growth was mainly attributed due to presence of large patient pool diagnosed with chronic diseases such as asthma and chronic pulmonary obstructive diseases (COPD) in this region. Also, manufacturers are expanding their operations in Asian countries such as India, China, Japan and South Korea. For example, Omron Healthcare, Inc., established its subsidiary in South Korea to sell its nebulizers in this region. Thus, all the above mentioned factors collectively supports the growth of nebulizers market in Asia-Pacific region. Some of the key players having presence in the global nebulizers market are Philips Healthcare, Omron Healthcare, GF Health Products, Inc. and PARI Respiratory, Inc. Nebulizers Market, by Product Types - Pneumatic Nebulizer - Vented Pneumatic Nebulizers - Breath-Actuated Pneumatic Nebulizers - Ultrasonic Nebulizers - Stand Alone Ultrasonic Nebulizers - Portable Ultrasonic Nebulizers - Mesh Nebulizers - Static Mesh Nebulizers - Vibrating Mesh Nebulizers Company Profiles - Agilent Technologies, Inc. - Allied Healthcare Products, Inc. - CareFusion Corporation - Covidien plc - GE Healthcare Ltd. - GF Health Products, Inc. - Omron Healthcare, Inc. - PARI Respiratory Equipment, Inc. - Philips Healthcare For more information visit http://www.researchandmarkets.com/research/l9...ers_market
A: 40.15 (+0.13), AHPI: 1.56 (unch)
How it All Plays Out: Research Reports on Align Technology, Alimera, Alkermes, Alliance HealthCare Services, and Allied Healthcare Products
PR Newswire - Tue Feb 03, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Align Technology (NASDAQ: ALGN), Alimera (NASDAQ: ALIM), Alkermes (NASDAQ: ALKS), Alliance HealthCare Services, (NASDAQ: AIQ), and Allied Healthcare Products (NASDAQ: AHPI). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ALGN: 56.90 (-0.34), ALIM: 5.16 (unch), AHPI: 1.56 (unch), ALKS: 71.40 (-1.89), AIQ: 24.99 (+0.27)
Global COPD and Asthma Devices Market (Product Types and Geography) 2013 - 2020
M2 - Wed Dec 03, 8:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/8nv92w/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020" report to their offering. The global COPD and asthma devices market would reach $34.3 billionby 2020, registering a CAGR of 4.5% during 2014 - 2020. Considering the growth and market size, Dry Powder Inhalers (DPIs) will be the most lucrative market segment of the COPD and Asthma devices (inhalers) market by 2020. Metered Dose Inhalers (MDIs) are the largest revenue generating segment currently and would maintain the stand till 2020. The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices. Despite notable advantages of the COPD and Asthma devices, some factors such as environmental concerns are likely to impede the growth of COPD and Asthma devices market. It is observed that the inhalers, particularly the MDIs, release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is negatively impacting growth of the MDIs segment. Consumption pattern will shift to better alternatives, namely the DPIs. The Soft Mist Inhalers (SMIs), which are another type of inhalers, deliver metered dosage of medication as a soft mist. Such form of drug delivery is -65% to 80% more efficacious than its peers and will eventually display higher growth as compared to its peers. Nebulizers, electric or battery powered machines that dispense medication as a fine mist, are ideal for home healthcare set-up for debilitated patients, geriatrics and children. Nebulizers segment thus holds about 13% of the global COPD and Asthma devices market; however, the nebulizers market is forecast to have diminishing growth through 2020 as nebulizers are rendered ineffectual, as POC or portable COPD and Asthma devices due to its larger set up. Key findings of the study: - Drug powder inhalers (DPIs) segment will grow at a CAGR of 5.3% during the forecast period, fastest among all - North American market would be one of the most lucrative markets, in terms of growth - European market for COPD and asthma devices would reach $10 billion by 2020, with the CAGR of 4.8% - Within the nebulizers segment markets, compressor nebulizers would be most lucrative, growing at 7% CAGR during the forecast period and compressor nebulizers would garner 81.5% market share by 2020 Specific focus to achieve product differentiation and thus gain competitive advantage drives the development of new product variants of COPD and Asthma devices. In accordance to the afore-mentioned trend, the market has witnessed steady stream of product launch. Key product manufacturing companies profiled in the report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc. and Baxter International. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL COPD AND ASTHMA DEVICES MARKET BY PRODUCT TYPE, 2013-2020, $MILLION CHAPTER 5 GLOBAL COPD AND ASTHMA DEVICES MARKET BY GEOGRAPHY, 2013-2020, $MILLION CHAPTER 6 COMPANY PROFILES - 3M Health Care - Allied Healthcare Products Inc. - AstraZeneca Plc - Baxter International - GF Healthcare Products - GlaxoSmithKline Plc - Lincare Holdings Inc. - Merck & Co. - Novartis AG - Philips Healthcare - Smith Medicals - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/8n...l_copd_and
BAX: 70.39 (+0.31), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), AHPI: 1.56 (unch), GSK: 47.94 (+1.99), NVS: 102.20 (-0.17)
OTC Daily Alert Stock Watch - Allied Healthcare Products, Inc (NASDAQ: AHPI)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
AHPI: 1.56 (unch)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 17.13 (+0.15), COV: 106.71 (-1.36), AHPI: 1.56 (unch)
Nasdaq stocks posting largest volume increases
AP - Fri Oct 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
URBN: 38.47 (+0.27), DLHC: 2.21 (-0.06), LMOS: 17.98 (-0.14), RDI: 12.03 (unch), AHPI: 1.56 (unch), COCO: 0.02 (-0.01), AGYS: 10.06 (-0.16), HCCI: 12.05 (-0.14), NAUH: 3.17 (-0.02), KTEC: 12.53 (-0.02), MBTF: 5.37 (-0.01), CZFC: 12.30 (-0.03), RDIB: 12.31 (-0.07)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 11:52AM CDT
TTPH: 35.18 (-0.73), MNOV: 3.62 (-0.56), DLHC: 2.21 (-0.06), RADA: 2.46 (+0.01), ESI: 7.58 (-0.29), RPRX: 8.76 (+0.09), VSR: 3.42 (-0.02), HCCI: 12.05 (-0.14), ANR: 1.27 (+0.03), BIOF: 7.28 (+0.01), URBN: 38.47 (+0.27), GBIM: 7.85 (+0.25), APT: 2.88 (+0.17), NLNK: 38.84 (+1.51), AHPI: 1.56 (unch), LIME: 2.69 (+0.14), QLGC: 14.48 (+0.48), WLB: 28.91 (+0.29), IBIO: 0.90 (+0.36), VPCO: 1.02 (+0.01)
Second healthcare worker contracts Ebola in U.S.
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 4:25AM CDT
BCRX: 10.06 (-0.09), DAL: 44.50 (-0.31), SHO: 17.49 (-0.14), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), H: 59.51 (-0.14), HOT: 78.55 (+0.67), STAY: 20.74 (+0.21), LUV: 43.30 (-0.20), INO: 6.80 (-0.15), INN: 13.05 (+0.08), HLT: 28.57 (+0.13), CHH: 61.75 (+1.14), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), SRPT: 12.76 (+0.11), NLNK: 38.84 (+1.51), AHPI: 1.56 (unch), IBIO: 0.90 (+0.36), LAKE: 10.18 (+0.89), AAL: 48.39 (+0.51), IHG: 40.34 (-1.03), NSPH: 0.25 (unch), HA: 18.72 (-0.31), AHT: 10.63 (-0.04), LHO: 41.14 (-0.08), VSR: 3.42 (-0.02), GSK: 47.94 (+1.99), MAR: 79.39 (+0.37), ALGT: 178.42 (-4.07), UAL: 66.23 (-1.11), SKYW: 13.84 (+1.88), HEB: 0.25 (+0.01), PLX: 1.84 (-0.04), SMED: 4.75 (-0.04)
Market Maker Surveillance Report. AHPI, APT, LAKE, IBIO, CDXS, MPO, Losing Stocks With Lowest Price Friction For Tuesday, October 14th 2014
M2 - Wed Oct 15, 3:11AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4904 companies with "abnormal" market making, 2632 companies with positive Friction Factors and 2319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Allied Healthcare Products Inc (NASDAQ:AHPI), Alpha Pro Tech Ltd (NYSE:APT), Lakeland Industries Inc (NASDAQ:LAKE), Ibio Inc (NYSE:IBIO), Codexis Inc (NASDAQ:CDXS), Midstates Petroleum Company Inc (NYSE:MPO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
APT: 2.88 (+0.17), AHPI: 1.56 (unch), MPO: 1.00 (-0.02), CDXS: 3.42 (+0.07), IBIO: 0.90 (+0.36), LAKE: 10.18 (+0.89)
Global Nebulizers Market Industry Analysis 2014-2019 - Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers
M2 - Mon Sep 01, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l9s298/nebulizers_market) has announced the addition of the "Nebulizers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global nebulizers market was valued at USD 610.0 million in 2012 and is expected to grow at a CAGR of 6.5% from 2013 to 2019, to reach an estimated value of USD 937.7 million by 2019. The global nebulizers market is segmented based on product types into pneumatic nebulizer, ultrasonic nebulizer and mesh nebulizer. In 2012, pneumatic nebulizer accounted for the largest market share of the global nebulizers market owing to its cost effective nature and easy to handle. Pneumatic nebulizers are further classified as vented and breath-actuated pneumatic nebulizers. In 2012, breath actuated pneumatic nebulizers segment accounted for the largest share of the global pneumatic nebulizers market due to factors such as cost effectiveness and efficient drug delivery. Moreover, the breath-actuated pneumatic nebulizers segment is expected to grow at the highest CAGR from 2013 to 2019 in the global pneumatic nebulizers market. Ultrasonic nebulizers are further segmented into standalone and portable ultrasonic nebulizers. Portable ultrasonic nebulizers accounted for the largest share as they are easy to handle and operate. North America accounted for the largest share in the global nebulizers market in 2012 owing to rising prevalence of respiratory diseases such as asthma, COPD and cystic fibrosis. In addition, increasing government initiatives in this region also supported the growth of nebulizers market in the North American region. Asia-Pacific was observed to be an emerging market for nebulizers and is expected to grow at the highest CAGR from 2013 to 2019. This growth was mainly attributed due to presence of large patient pool diagnosed with chronic diseases such as asthma and chronic pulmonary obstructive diseases (COPD) in this region. Also, manufacturers are expanding their operations in Asian countries such as India, China, Japan and South Korea. For example, Omron Healthcare, Inc., established its subsidiary in South Korea to sell its nebulizers in this region. Thus, all the above mentioned factors collectively supports the growth of nebulizers market in Asia-Pacific region. Some of the key players having presence in the global nebulizers market are Philips Healthcare, Omron Healthcare, GF Health Products, Inc. and PARI Respiratory, Inc. Nebulizers Market, by Product Types - Pneumatic Nebulizer - Vented Pneumatic Nebulizers - Breath-Actuated Pneumatic Nebulizers - Ultrasonic Nebulizers - Stand Alone Ultrasonic Nebulizers - Portable Ultrasonic Nebulizers - Mesh Nebulizers - Static Mesh Nebulizers - Vibrating Mesh Nebulizers Company Profiles - Agilent Technologies, Inc. - Allied Healthcare Products, Inc. - CareFusion Corporation - Covidien plc - GE Healthcare Ltd. - GF Health Products, Inc. - Omron Healthcare, Inc. - PARI Respiratory Equipment, Inc. - Philips Healthcare For more information visit http://www.researchandmarkets.com/research/l9...ers_market
A: 40.15 (+0.13), AHPI: 1.56 (unch)
